pRelA*
(Plasmid
#175590)
-
PurposeTet inducible, KAN Resistant, fluor labelled (YFP) synthesis domain of the E. coli relA gene on a low copy backbone. Used to induce controllable synthesis of ppGpp in E. coli.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 175590 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepBbS2k
-
Backbone manufacturerBglBrick
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert nameCatalytic domain of E.coli relA gene.
-
Alt namerelA'
-
SpeciesE. coli
-
Insert Size (bp)1365
-
MutationOnly the catalytic domain of the enzyme is used (C Terminal Domain [CTD] of WT RelA is removed). AGGAGGAAAAAA RBS sequence added before the start codon.
-
GenBank ID947244
-
Tag
/ Fusion Protein
- Fused with a flexible GS linker to mVenus (C terminal on insert)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byRelA* is a fusion of RelA'_YFP, RelA' is cloned from E.coli genomic DNA, YFP was cloned from the Addgene plasmid mVenus N1, Plasmid #27793
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pRelA* was a gift from Greg Bokinsky (Addgene plasmid # 175590 ; http://n2t.net/addgene:175590 ; RRID:Addgene_175590) -
For your References section:
ppGpp is a bacterial cell size regulator. Buke F, Grilli J, Cosentino Lagomarsino M, Bokinsky G, Tans SJ. Curr Biol. 2022 Feb 28;32(4):870-877.e5. doi: 10.1016/j.cub.2021.12.033. Epub 2022 Jan 5. 10.1016/j.cub.2021.12.033 PubMed 34990598